ALIASINT Trademark

Trademark Overview

On Wednesday, July 26, 2017, a trademark application was filed for ALIASINT with the United States Patent and Trademark Office. The USPTO has given the ALIASINT trademark a serial number of 87544327. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 1, 2021. This trademark is owned by IBSA INSTITUT BIOCHIMIQUE S.A.. The ALIASINT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pituitary and thyroid diseases and disorders
aliasint

General Information

Serial Number87544327
Word MarkALIASINT
Filing DateWednesday, July 26, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pituitary and thyroid diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 1, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIBSA INSTITUT BIOCHIMIQUE S.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressMASSAGNO 6900
CH
Party NameIBSA INSTITUT BIOCHIMIQUE S.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
Address6900 MASSAGNO
CH

Trademark Events

Event DateEvent Description
Monday, March 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, March 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 12, 2020EXTENSION 5 GRANTED
Tuesday, March 3, 2020EXTENSION 5 FILED
Thursday, March 12, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 3, 2020TEAS EXTENSION RECEIVED
Friday, October 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2019EXTENSION 4 GRANTED
Wednesday, October 23, 2019EXTENSION 4 FILED
Wednesday, October 23, 2019TEAS EXTENSION RECEIVED
Friday, May 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2019EXTENSION 3 GRANTED
Wednesday, May 1, 2019EXTENSION 3 FILED
Wednesday, May 1, 2019TEAS EXTENSION RECEIVED
Thursday, September 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 4, 2018EXTENSION 2 GRANTED
Tuesday, September 4, 2018EXTENSION 2 FILED
Tuesday, September 4, 2018TEAS EXTENSION RECEIVED
Saturday, January 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2018EXTENSION 1 GRANTED
Thursday, January 25, 2018EXTENSION 1 FILED
Thursday, January 25, 2018TEAS EXTENSION RECEIVED
Tuesday, January 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2017ASSIGNED TO EXAMINER
Tuesday, August 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 29, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

aliasint diseases disorders thyroid pituitary preparations treatment pharmaceutical